BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10707823)

  • 41. [Experimental anatomo-pathologic study in the myocardium of animals with arterial hypertension caused via a nitric oxide synthesis blocker].
    Xavier-Vidal R; Madi K; de Lima RJ; Marques NM; Reis Ade A; Paes Lda S
    Rev Port Cardiol; 1999 Apr; 18(4):381-91. PubMed ID: 10371846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiplexed immunoassays for simultaneous quantification of cardiovascular biomarkers in the model of H(G)-nitro-L-arginine methylester (L-NAME) hypertensive rat.
    Adamcova M; Ruzickova S; Simko F
    J Physiol Pharmacol; 2013 Apr; 64(2):211-7. PubMed ID: 23756396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of blood pressure by L-arginine-nitric oxide pathway within the superior colliculus of rats.
    D'Amico M; Rossi F; Warner TD
    Eur J Pharmacol; 1997 Jun; 328(1):65-7. PubMed ID: 9203570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Nomega-nitro-L-arginine methyl ester-induced intrauterine growth restriction on postnatal lung growth in rats.
    Diaz V; Lebras-Isabet MN; Denjean A
    Pediatr Res; 2005 Sep; 58(3):557-61. PubMed ID: 16148073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues.
    Pechánová O; Bernátová I
    Physiol Res; 1996; 45(4):305-9. PubMed ID: 9085354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
    Sanada S; Node K; Minamino T; Takashima S; Ogai A; Asanuma H; Ogita H; Liao Y; Asakura M; Kim J; Hori M; Kitakaze M
    Hypertension; 2003 Apr; 41(4):963-7. PubMed ID: 12629037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitric oxide synthesis blockade increases hypertrophy and cardiac fibrosis in rats submitted to aerobic training.
    Souza HC; Penteado DM; Martin-Pinge MC; Barbosa Neto O; Teixeira Vde P; Blanco JH; Silva VJ
    Arq Bras Cardiol; 2007 Aug; 89(2):88-93, 99-104. PubMed ID: 17874014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-specific inhibitors of nitric oxide synthase cause myocardial necrosis in the rat.
    Moreno Júnior H; Nathan LP; Metze K; Costa SK; Antunes E; Hyslop S; Zatz R; de Nucci G
    Clin Exp Pharmacol Physiol; 1997 May; 24(5):349-52. PubMed ID: 9143786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase.
    Sládek T; Gerová M; Znojil V; Devát L
    Physiol Res; 1996; 45(4):335-8. PubMed ID: 9085359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats.
    Matsubara BB; Matsubara LS; Zornoff LA; Franco M; Janicki JS
    Basic Res Cardiol; 1998 Jun; 93(3):173-81. PubMed ID: 9689443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O
    Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension.
    Pechánová O; Bernátová I; Babál P; Martínez MC; Kyselá S; Stvrtina S; Andriantsitohaina R
    J Hypertens; 2004 Aug; 22(8):1551-9. PubMed ID: 15257179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carotid body remodelling in l-NAME-induced hypertension in the rat.
    Felix AS; Rocha VN; Nascimento AL; de Carvalho JJ
    J Comp Pathol; 2012 May; 146(4):348-56. PubMed ID: 21899859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
    Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE
    Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of structural remodelling of the rat aorta during long-term NG-nitro-L-arginine methyl ester treatment.
    Bernátová I; Pechánová O; Kristek F
    Jpn J Pharmacol; 1999 Sep; 81(1):99-106. PubMed ID: 10580377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of propolis on biochemical parameters in kidney and heart tissues against L-NAME induced oxidative injury in rats.
    Talas ZS; Ozdemir I; Ciftci O; Cakir O; Gulhan MF; Pasaoglu OM
    Clin Exp Hypertens; 2014; 36(7):492-6. PubMed ID: 24490594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term inhibition of NO synthase induces cardiac hypertrophy with a decrease in adrenergic innervation.
    Gerová M; Hartmannová B; Dolezel S; Jezek L
    Physiol Res; 1996; 45(4):339-44. PubMed ID: 9085360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition.
    Mandarim-De-Lacerda CA; Meirelles Pereira LM
    Pathobiology; 2000; 68(1):36-42. PubMed ID: 10859529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term NO synthase inhibition affects heart weight and geometry of coronary and carotid arteries.
    Kristek F; Gerová M
    Physiol Res; 1996; 45(5):361-7. PubMed ID: 9085363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereology of the myocardium in hypertensive rats. Differences in relation to the time of inhibition of nitric oxide synthesis.
    Pereira LM; Vianna GM; Mandarim-de-Lacerda CA
    Virchows Arch; 1998 Oct; 433(4):369-73. PubMed ID: 9808439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.